#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic angiosarcoma Malignant neoplasm of choroid Small cell lung cancer extensive stage Hypomagnesaemia Amyloidosis Mycobacterium abscessus infection Acute promyelocytic leukaemia Sickle cell disease Desmoplastic small round cell tumour Acquired haemophilia Cytokine release syndrome Cutaneous T-cell lymphoma refractory Microscopic polyangiitis Mucous membrane pemphigoid Congenital absence of bile ducts More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Life with Disease Retinoblastoma – Trials in Disease Netherton’s syndrome – Life with Disease Prolymphocytic leukaemia – Life with Disease Osteosarcoma recurrent – Diagnostics Nodal marginal zone B-cell lymphoma – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Chondrosarcoma metastatic – Treatment Tuberous sclerosis complex Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adrc GS-1720 Minzasolmin Zimberelimab Dolutegravir Sodium Niraparib Venlafaxine Hydrochloride Ciclosporin Gandotinib Haloperidol Decanoate Fasudil Hydrochloride Rucaparib Remifentanil Hydrochloride Erythromycin Rbd5044 Sodium Travoprost Batoprotafib Aprepitant Poractant Alfa Neridronate Sodium More therapies…

    Learn about Your Condition

    Ocular myasthenia Uveitis Ebola disease Thrombectomy Raynaud's phenomenon Polymyalgia rheumatica Proteus syndrome Emphysema Diabetic foot infection Haemolytic uraemic syndrome Spinal muscular atrophy Herpes virus infection Neoplasm Leber's congenital amaurosis Gastrectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Hydrocortisone Sodium Succinate
    • Prednisolone Sodium Succinate
    • Imatinib
    Belgium Denmark Estonia Finland France Germany +8

  • Study of Clofarabine for Patients with Advanced or Metastatic Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Clofarabine
    Austria

  • Study on Clopidogrel and Acetylsalicylic Acid for Patients with Coronary Artery Disease and Non-ST-segment Elevation Acute Coronary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    The Netherlands

  • Study on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer recurrent
    • Endometrial cancer
    • Ovarian cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Dostarlimab
    France Italy Spain

  • Study on Nepafenac and Dexamethasone for Reducing Inflammation and Swelling in Fuchs Dystrophy Patients After Corneal Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Nepafenac
    • Dexamethasone
    Norway

  • Evaluation of inhaled formoterol fumarate to prevent lung complications after chest cancer surgery in high-risk patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Formoterol Fumarate
    France
Previous Page
1 … 612 613 614 615 616 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!